Angiotensin-converting enzyme and angiotensin II type 1 receptor gene polymorphisms in children with subacute sclerosing panencephalitis

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 141, Issue 5, 2006, Pages 445-448

  Taşdemir, Nebahat ^a   Ece, Aydin ^a   Tekeş, Selahattin ^a   Dikici, Süber ^a,b   Güneş, Ali ^a   Balik, Hasan ^a  

^a DICLE UNIVERSITY   (Turkey)

^b Diyarbakir Devlet Hastanesi   (Turkey)

Author keywords

ACE; AT1R; Gene polymorphism; Pathogenesis; SSPE

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; DIPEPTIDYL CARBOXYPEPTIDASE; GENOMIC DNA; IMMUNOGLOBULIN G; MEASLES ANTIBODY;

ADULT; ANTIBODY TITER; ARTICLE; ATAXIA; AUTOIMMUNITY; BRAIN BIOPSY; CELL NUCLEUS INCLUSION BODY; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DEMYELINATION; ELECTROENCEPHALOGRAPHY; ENZYME ACTIVITY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN TISSUE; MALE; MEASLES VIRUS; MYOCLONUS; NEUROFIBRILLARY TANGLE; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEIZURE; STATISTICAL ANALYSIS; SUBACUTE SCLEROSING PANENCEPHALITIS; TURKEY (REPUBLIC); VIRUS MUTANT;

ADULT; ALLELES; CHILD; CHILD, PRESCHOOL; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; RECEPTOR, ANGIOTENSIN, TYPE 1; SUBACUTE SCLEROSING PANENCEPHALITIS;

MEASLES VIRUS;

EID: 33745788188     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.30343     Document Type: Article

References (29)

1. Barrett PN, Koschel K, Carter M, ter Meulen V. 1985. Effect of measles virus antibodies on a measles SSPE virus persistently infected C6 rat glioma cell line. J Gen Virol 66:1411-1421.
2. Cambien F, Pairer O, Lecerf F, Evans A, Cambau JP, Arveiller D, Luc G, Bard J, Bara L, Ricard S. 1992. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 359:641-644.
3. Ece A, Tekeş S, Gürkan F, Bilici M, Budak T. 2005. Polymorphisms of the angiotensin converting enzyme and angiotensin II type 1 receptor genes and renal scarring in non-uropathic children with recurrent urinary tract infection. Nephrology 10:377-381.
4. Forrester T, McFarlane-Anderson N, Bennett FI, Wilks R, Cooper R, Rotimi C, Morrison L, Ward R. 1997. The angiotensin converting enzyme and blood pressure in Jamaicans. Am J Hypertens 10:519-524.
5. Gascon GC. 1996. Subacute sclerosing panencephalitis. Semin Pediatr Neurol 3:260-269.
6. Gascon GG. 2003. International Consortium on Subacute Sclerosing Panencephalitis. Randomized treatment study of inosiplex versus combined inosiplex and intraventricular interferon-alpha in subacute sclerosing panencephalitis (SSPE): International multicenter study. J Child Neurol 18:819-827.
7. Griffin DE, Ward BJ, Esolen LM. 1994. Pathogenesis of measles virus infection: A hypothesis for accelerated immune responses. J Infect Dis 170:824-831.
8. Hara T, Yamashita S, Aiba H, Nihei K, Koide N, Good RA, Takeshita K. 2000. Measles virus specific T helper 1/T helper 2-cytokine production in subacute sclerosing panencephalitis. J Neurovirol 6:121-126.
9. Harding D, Baines PB, Brull D, Vassiliou V, Ellis I, Hart A, Thomson AP, Humphries SE, Montgomery HE. 2002. Severity of meningococcal disease in children and the angiotensin-converting enzyme insertion/deletion polymorphism. Am J Respir Crit Care Med 15:1103-1106.
10. Inoue T, Kira R, Nakao F, Ihara K, Bassuny WM, Kusuhara K, Nihei K, Takeshita K, Hara T. 2002. Contribution of the interleukin 4 gene to susceptibility to subacute sclerosing panencephalitis. Arch Neurol 59: 822-827.
11. Jeunemaitre X, Soubrier F, Kotelevtsev YV, Lifton RP, Williams CS, Charm A, Hunt S, Hopkins P, Williams R, Llouel JM, Corvol P. 1992. Molecular basis for human hypertension: Role for angiotensinogen. Cell 71:169-180.
12. Kario T, Kanai N, Saito K. 1996. Ischemic stroke and the gene for angiotensin-converting enzyme in Japanese hypertensives. Circulation 93:1630-1633.
13. Kehoe PG, Russ C, McIlroy S, Wiliams H, Holmans P, Holmes C, Liolitsa D, Vahidassr D, Powell J, McGleenon B, Liddell M, Plomin R, Dynan K, Williams N, Neal J, Cairns NJ, Wilcock G, Passmore P, Lovestone S, Wiliams J, Owen M. 1999. Variation in DCP1, encoding ACE is associated with susceptibility to Alzheimer disease. Nat Genet 21:71-72.
14. Kusuhara K, Sasaki Y, Nakao F, Ihara K, Hattori H, Yamashita S, Nihei K, Koide N, Aiba H, Takeshita K, Hara T. 2000. Analysis of measles virus binding sites of the CD46 gene in patients with subacute sclerosing panencephalitis. J Infect Dis 181:1447-1449.
15. Lazarus DS, Aschoff J, Fangurg BL, Lanzillo JJ. 1994. Angiotensin-converting enzyme (kininase II) mRNA production and enzymatic activity in human peripheral blood monocytes are induced by GM-CSF but not by other cytokines. Biochem Biophys Acta 1226:12-18.
16. Liu KP, Lin CY, Chen HJ, Wei CF, Lee-Chen GJ. 2004. Renin-angiotensin polymorphisms in Taiwanese primary vesicoureteral reflux. Pediatr Nephrol 19:594-601.
17. Mellick GD, Buchanan DD, McCann SJ, Davis DR, Le Couteur DG, Chan D, Johnson AG. 1999. The ACE deletion polymorphism is not associated with Parkinson's disease. Eur Neurol 41:103-106.
18. Miller SA, Dykes DD, Polesky HS. 1988. Simple salting out procedure for extraction DNA from human nucleoted cells. Nucleic Acid Res 16:1215-1219.
19. Nataraj C, Oliverio MI, Mannon RB, Mannon PJ, Audoly LP, Amuchastegui CS, Ruiz P, Smithies O, Coffman TM. 1999. Angiotensin II regulates cellular immune responses through a calcineurin-dependent pathway. J Clin Invest 104:1693-1701.
20. Parsa A, Peden E, Lum RF, Seligman VA, Olson JL, Li H, Seldin MF, Criswell LA. 2002. Association of angiotensin-converting enzyme polymorphisms with systemic lupus erythematosus and nephritis: Analysis of 644 SLE families. Genes Immunity 2:S42-S46.
21. Rima BK, Duprex WP. 2005. Molecular mechanisms of measles virus persistence. Virus Research 111:132-147.
22. Ruiz-Ortega M, Lorenzo O, Suzuki Y, Ruperez M, Egido J. 2001. Proinflammatory actions of angiotensins. Curr Opin Nephrol Hypertens 10:321-329.
23. Schneider-Schaulies J, Niewiesk S, Schneider-Schaulies S, ter Meulen V. 1999. Measles virus in the CNS: The role of viral and host factors for the establishment and maintenance of a persistent infection. J Neurovirol 5:613-622.
24. Sokol SI, Portnay EL, Curtis JP, Nelson MA, Hebert PR, Setaro JF, Foody JM. 2004. Modulation of the renin-angiotensin-aldosteron system for the secondary prevention of stroke. Neurology 2:208-213.
25. Suzuki Y, Ruiz-Ortega M, Lorenzo O, Ruperez M, Esteban V, Egido J. 2003. Inflammation and angiotensin II. Int J Biochem Cell Biol 35:881-900.
26. Takasu T, Mgone JM, Mgone CS, Miki K, Komase K, Namae H, Saito Y, Kokubun Y, Nishimura T, Kawanishi R, Mizutani T, Markus TJ, Kono J. Asuo PG, Alpers MP. 2003. A continuing high incidence of subacute sclerosing panencephalitis (SSPE) in the Eastern Highlands of Papua New Guinea. Epidemiol Infect 131:887-898.
27. Torisu H, Kusuhara K, Kira R, Bassuny WM, Sakai Y, Sanefuji M, Takemoto M, Hara T. 2004. Functional MxA promoter polymorphism associated with subacute sclerosing panencephalitis, Neurology 62:457-460.
28. Woods DR, Humphries SE, Montgomery HE. 2000. The ACE I/D polymorphism and human physical performance. TEM 11:416-420.
29. Yalaz K, Anlar B, Oktem F, Aysun S, Ustacelebi S, Gurcay O, Gucuyener K, Renda Y. 1992. Intraventricular interferon and oral inosiplex in the treatment of subacute sclerosing panencephalitis. Neurology 42:488-491.